Generation Bio Acquired by XOMA Royalty for $4.2913

XOMA Royalty completed its previously announced tender offer to acquire all outstanding shares of Generation Bio Co. at $4.2913 per share in cash plus one non-tradeable contingent value right (CVR). The tender offer expired one minute after 11:59 p.m. Eastern Time on February 6, 2026.

As of the expiration date, 4,722,533 shares were validly tendered and not withdrawn, representing about 70% of Generation Bio’s outstanding shares. After the tender offer, a subsidiary of XOMA Royalty merged with and into Generation Bio, making Generation Bio a wholly owned subsidiary and ending Nasdaq trading for its shares.